NorthWest Biotherapeutics Inc (NWBO)

[Schnauzer1]

Thanks for the update. The substance of LP's statement (in London) around IL-8 is that its efficacy is a new discovery and its efficacy action is counter-intuitive to what was believed before. Perhaps Dr. Bosch thought it had impact and effectiveness but apparently there was no proof of efficacy. So LP is saying that everyone is different and produces different amounts of IL-8, but that its measurable even at completion of manufacturing. Why would she paint this as a new significant discovery?

She says the amount of production of IL-8 directly correlates to survival. Perhaps NWBO now has a new predictive tool to determine survival prospects. If that is true, of course, then they would want to employ that tool as soon as possible.

Just a note on the issue of inflammation of the cranial cavity, since the tumor is resectioned it would seem that such swelling would not be dramatic regardless of the responsiveness of the L product. Again, it appears to me that the responsive issues discovered for Direct would be equally applicable for L.